TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,630,000 | +75.6% | 114,674 | 0.0% | 0.02% | +60.0% |
| Q2 2020 | $928,000 | +233.8% | 114,674 | +282.2% | 0.02% | -37.5% |
| Q1 2016 | $278,000 | -26.5% | 30,000 | 0.0% | 0.02% | -14.3% |
| Q4 2015 | $378,000 | -51.7% | 30,000 | -50.0% | 0.03% | -9.7% |
| Q3 2015 | $782,000 | +19.4% | 60,000 | +100.0% | 0.03% | -20.5% |
| Q2 2015 | $655,000 | – | 30,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|